1. Home
  2. PHVS vs DK Comparison

PHVS vs DK Comparison

Compare PHVS & DK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • DK
  • Stock Information
  • Founded
  • PHVS 2015
  • DK 2001
  • Country
  • PHVS Netherlands
  • DK United States
  • Employees
  • PHVS N/A
  • DK N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • DK Integrated oil Companies
  • Sector
  • PHVS Health Care
  • DK Energy
  • Exchange
  • PHVS Nasdaq
  • DK Nasdaq
  • Market Cap
  • PHVS 1.0B
  • DK 1.2B
  • IPO Year
  • PHVS 2021
  • DK 2006
  • Fundamental
  • Price
  • PHVS $22.29
  • DK $18.61
  • Analyst Decision
  • PHVS Buy
  • DK Sell
  • Analyst Count
  • PHVS 6
  • DK 10
  • Target Price
  • PHVS $35.67
  • DK $21.22
  • AVG Volume (30 Days)
  • PHVS 67.6K
  • DK 1.3M
  • Earning Date
  • PHVS 11-13-2024
  • DK 11-06-2024
  • Dividend Yield
  • PHVS N/A
  • DK 5.48%
  • EPS Growth
  • PHVS N/A
  • DK N/A
  • EPS
  • PHVS N/A
  • DK N/A
  • Revenue
  • PHVS N/A
  • DK $13,870,800,000.00
  • Revenue This Year
  • PHVS N/A
  • DK N/A
  • Revenue Next Year
  • PHVS N/A
  • DK N/A
  • P/E Ratio
  • PHVS N/A
  • DK N/A
  • Revenue Growth
  • PHVS N/A
  • DK N/A
  • 52 Week Low
  • PHVS $15.37
  • DK $15.36
  • 52 Week High
  • PHVS $33.00
  • DK $33.60
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 54.95
  • DK 56.44
  • Support Level
  • PHVS $18.81
  • DK $17.76
  • Resistance Level
  • PHVS $21.85
  • DK $19.67
  • Average True Range (ATR)
  • PHVS 1.44
  • DK 0.80
  • MACD
  • PHVS -0.17
  • DK 0.16
  • Stochastic Oscillator
  • PHVS 52.81
  • DK 74.46

About PHVS Pharvaris N.V.

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. Delek's logistics segment sells portions of the petroleum products its refineries produce. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

Share on Social Networks: